Physician profile
Anthony R Wright
NPI 1841266517
$987.26
in general payments reported to CMS, 2019-2025
13 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $27.52 · 2021: $11.21 · 2022: $99.51 · 2023: $421 · 2024: $27.44 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $153.96 | 2021-2023 | Farxiga |
| Lilly USA, LLC | $147.05 | 2019-2023 | Mounjaro, Emgality, Jardiance |
| Mimedx Group, INC. | $142.03 | 2025 | |
| Smith+Nephew, INC. | $123.55 | 2023 | Versajet |
| Novo Nordisk INC | $96.62 | 2019-2023 | Rybelsus, Ozempic |
| Abbvie INC. | $85.15 | 2023-2025 | Ubrelvy |
| Abbott Laboratories | $72.05 | 2019 | |
| Arthrex, INC. | $63.65 | 2025 | |
| Alk-Abello, INC | $37.66 | 2023 | Odactra, Grastek, Ragwitek |
| Astellas Pharma US INC | $18.56 | 2019 | |
| Boston Scientific Corporation | $16.15 | 2019 | |
| Allergan, INC. | $15.80 | 2020 | |
| Antares Pharma, INC. | $15.03 | 2023 | Nocdurna, Xyosted, Tlando |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.